Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.451

-2.1%

10:07 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (152)	3/9/2005 9:42:24 AM
From: Mike McFarland	Read Replies (1) of 368

Margaret Liu, M.D. to Board of Directors (snip) Margaret A. Liu earned her B.A. in Chemistry, Summa Cum Laude, from Colorado College and an M.D. from Harvard Medical School. She completed Internship and Residency in Internal Medicine and a Fellowship in Endocrinology at Massachusetts General Hospital. She received Board Certification in Internal Medicine and in Endocrinology and Metabolism. Dr. Liu was a Visiting Scientist at the Massachusetts Institute of Technology and an instructor at Harvard Medical School. Dr. Liu is currently Visiting Professor at the Karolinska Institutet in Stockholm and Vice-Chairman of the Board of Transgene in Strasbourg. In addition to these duties, she serves as a member of the NIH NIAID Council (an appointment made by the US Secretary of Health and Human Services), chairman of the Scientific Advisory Group of the International Vaccine Institute (in Seoul), a member of the Board of Directors of the Keystone Symposia, scientific advisor for AVAC (the AIDS Vaccine Advocacy Coalition), a member of the Advisory Board for the Elizabeth Glazer Pediatric AIDS Foundation Scholars Award, and a member of the External Scientific Advisory Committee of the Children's Hospital Oakland Research Institute. She is a former member of the following organizations: the European Developing Country Clinical Trials Partnership (EDCTP) Board, the WHO IVR VAC (WHO's Initiative for Vaccine Research, Vaccine Advisory Committee), and the GAVI R&D Task Force during its tenure. Dr. Liu is a founding editor or on the editorial board or advisory boards of various scientific journals and has been elected a member of the American Society for Clinical Investigation and a Fellow of the Molecular Medicine Society. In 2002, Discover magazine named Dr. Liu one of "The 50 Most Important Women Scientists." Her pioneering work in the area of DNA vaccines has led to her receipt of an honorary Doctorate of Science from Colorado College and numerous honorary lectureships.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next